
---
title: Coagulation Disorders (INICET Cheat Sheet)
markmap:
  colorFreezeLevel: 6
---

## Coagulation Disorders

### Inherited
- Hemophilia A (Factor VIII)
  - X-linked recessive
  - Severity based on factor level
  - Management: Factor VIII concentrate, Emicizumab, Desmopressin (mild)
  - Inhibitors: Develop against factor concentrate
- Hemophilia B (Factor IX)
  - X-linked recessive
  - Management: Factor IX concentrate
- Von Willebrand Disease (vWD)
  - Most common inherited bleeding disorder
  - Types: 1, 2A, 2B, 2M, 2N, 3
  - Diagnosis: VWF:Ag, VWF:RCo (activity), Factor VIII level, Multimer analysis
  - Management: Desmopressin (Type 1), VWF-containing factor concentrate
- Rare Factor Deficiencies (e.g., XI, VII, XIII)
- Inherited Platelet Disorders
  - Glanzmann Thrombasthenia (GPIIb/IIIa deficiency)
  - Bernard-Soulier Syndrome (GPIb-IX-V deficiency)
  - Storage pool deficiencies

### Acquired
- Disseminated Intravascular Coagulation (DIC)
  - Causes: Sepsis, Trauma, Malignancy, Obstetric
  - Labs: Low Plt, Low Fibrinogen, High PT/aPTT, High D-dimer, Schistocytes
  - Management: Treat underlying cause, Support
- Liver Disease
  - Decreased synthesis of most factors (except VIII)
  - Dysfibrinogenemia
  - Thrombocytopenia (splenomegaly, decreased TPO)
- Vitamin K Deficiency
  - Affects Factors II, VII, IX, X, Protein C & S
  - Causes: Malnutrition, Malabsorption, Antibiotics, Warfarin
  - Labs: High PT (most sensitive), then aPTT
- Anticoagulant Therapy
  - Warfarin: Vitamin K antagonist (PT/INR monitoring)
  - Heparin: Enhances Antithrombin (aPTT monitoring for UFH)
  - DOACs (NOACs): Direct Thrombin (Dabigatran) or Factor Xa inhibitors (Rivaroxaban, Apixaban, Edoxaban)
- Autoantibodies
  - Lupus Anticoagulant (Antiphospholipid Antibody Syndrome)
  - Acquired Hemophilia (Antibody against Factor VIII)
- Thrombocytopenia (ITP, TTP, HUS, HIT)
- Uremia
- Amyloidosis (Factor X deficiency)

### Evaluation
- Screening Tests
  - Prothrombin Time (PT): Extrinsic & Common pathway (Factors VII, X, V, II, I)
  - Activated Partial Thromboplastin Time (aPTT): Intrinsic & Common pathway (Factors XII, XI, IX, VIII, X, V, II, I)
  - Thrombin Time (TT): Fibrinogen to Fibrin
  - Fibrinogen Level
  - Platelet Count & Morphology
  - Bleeding Time (Historical, less used)
- Specific Tests
  - Mixing Study (Correction vs. Inhibition)
  - Specific Factor Assays
  - VWF studies (Ag, RCo, Multimers)
  - Platelet aggregation studies
  - D-dimer (Fibrinolysis marker)
  - ADAMTS13 activity (TTP)
  - Antiphospholipid antibodies (Lupus anticoagulant, Anticardiolipin, Beta2-glycoprotein I)

### Key Disorders Highlights
- Hemophilia: Joint bleeds, muscle hematomas
- vWD: Mucocutaneous bleeding (epistaxis, menorrhagia, GI bleeds)
- DIC: Thrombosis AND bleeding
- TTP: Pentad (FATRN): Fever, Anemia (microangiopathic hemolytic), Thrombocytopenia, Renal impairment, Neurological symptoms. Severe ADAMTS13 deficiency.
- HUS: Triad: Anemia (MAHA), Thrombocytopenia, Renal failure. Often post-diarrhea (STEC).
- ITP: Isolated thrombocytopenia, normal peripheral smear (except low Plt), mucocutaneous bleeding.

### Management Principles
- Treat underlying cause
- Factor Replacement (Concentrates, Recombinant)
- Desmopressin (DDAVP): Releases endogenous FVIII & vWF (useful for mild Hemophilia A, Type 1 vWD)
- Antifibrinolytics (Tranexamic acid, Aminocaproic acid)
- Immune Suppression (Steroids, IVIg for ITP, Acquired Hemophilia)
- Plasma Exchange (TTP)
- Procoagulant agents (PCC, rFVIIa for inhibitor patients)
- Emicizumab (Hemophilia A with or without inhibitors)

### INICET Buzzwords
- PT, aPTT, INR
- D-dimer, Fibrinogen
- Schistocytes
- Mixing Study
- Desmopressin (DDAVP)
- Factor VIII, IX, XI, VII, XIII
- VWF:Ag, VWF:RCo, Multimers
- Glanzmann, Bernard-Soulier
- Ristocetin cofactor
- ADAMTS13
- Lupus Anticoagulant, APLA
- DIC
- TTP Pentad (FATRN)
- MAHA
- ITP
- Warfarin, Heparin, DOACs/NOACs
- Vitamin K deficiency
- Liver failure
- Hemarthrosis
- Inhibitors
- Emicizumab
- Tranexamic acid
